Cardiac Substructure Dose Reduction and Toxicity Risk Assessment: IMPT Versus IMRT for Breast Cancer.

Int J Part Ther · 2025 · PMC12205686 · PMID 40584402

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

borderline significantP = .058so close (0.05 < p ≤ 0.1)

For right-sided patients, LV_V5 reaches zero, whereas using the MHD model, there remains a borderline significant benefit from IMPT in right-sided RNI with and without IMNI ( P = .058 and .063, respectively).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.